Adding Chemo to Endocrine Therapy Increases Cognitive Impairment in HR+, HER2- Breast Cancer

Adding chemotherapy to endocrine therapy leads to greater cognitive impairment in postmenopausal patients with breast cancer, a study suggests.

Related Keywords

California , United States , San Antonio , Texas , Irvine , Irene Kang , , San Antonio Breast Cancer Symposium , Hope Orange County ,